Fundraising FoxBeacon Intelligence
1 known investors
Find your way into Beacon Intelligence
Sign up to see every warm intro you have to Beacon Intelligence
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Beacon Intelligence team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Beacon provides a comprehensive drug development database for the life sciences industry, offering detailed intelligence on molecules, therapeutic targets, and companies across various disease areas and modalities. The platform serves biotech and pharmaceutical professionals seeking to analyze therapeutic development pipelines and make informed investment and strategic decisions.
Founders & leadership
R
RobLeader, Beacon and Intelligence business
Investors · 1
Companies House · registry record
View on Companies House ↗Accounts overdueConfirmation statement overdue
- Registered name
- BEACON INTELLIGENCE LIMITED
- Company number
- 11999310
- Status
- Active (active proposal to strike off)
- Company type
- Private limited company
- Incorporated
- 16 May 2019
- Registered office
- 71-75 Shelton Street, London, Greater London, WC2H 9JQ
- Nature of business (SIC)
- 62020 — Information technology consultancy activities
- Previous names
- DATAMOVEMENTS TRAINING LIMITED (2019–2019)
- Accounts
- last made up to 31 May 2024 · next due 28 Feb 2026
- Confirmation statement
- last made up to 15 May 2025 · next due 29 May 2026
Current officers · 1
- Neil Hambly — director, appointed 16 May 2019
Source: Companies House public register · retrieved 20 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Beacon Intelligence do?
- Beacon provides a comprehensive drug development database for the life sciences industry, offering detailed intelligence on molecules, therapeutic targets, and companies across various disease areas and modalities. The platform serves biotech and pharmaceutical professionals seeking to analyze therapeutic development pipelines and make informed investment and strategic decisions.
- Who are Beacon Intelligence's investors?
- Beacon Intelligence's investors include Ampersand.